H. Wagner

M. Levitt, A. Sandler, H. Wagner, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).

M. Gilbert, M. Mehta, J. Knisely, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508).

D. Carbone, Melissa L. Johnson, S. Ramalingam, 2020, Clinical lung cancer.

Postoperative adjuvant therapy for patients with resected non-small cell lung cancer: still controversial after all these years.

H. Wagner, 2000, Chest.

The Impact of Protocol Assignment for Older Adolescents with Hodgkin Lymphoma

T. Fitzgerald, M. Bishop-Jodoin, K. Ulin, 2014, Front. Oncol..

A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas

R. Hellman, D. Neuberg, P. Flynn, 1998, Journal of Neuro-Oncology.

Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593.

M. Mehta, D. Petereit, S. Adak, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.

S. Horning, D. Arber, T. Whiteside, 2020, Transfusion.

Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML

S. Mineishi, H. Shike, H. Wagner, 2018, International Journal of Hematology.

Teflon granuloma results in a false-positive "second primary" on 18F-2-deoxyglucose positron emission tomography in a patient with a history of nasopharyngeal cancer.

B. Stack, H. Wagner, Ayesha N. Khalid, 2007, American Journal of Otolaryngology.

An Evaluation of Bone Scans as Screening Procedures for Occult Metastases in Primary Breast Cancer

N. Khouri, P. Alderson, H. Wagner, 1977, Annals of surgery.

Evaluation of the International Prognostic Score (IPS‐7) and a Simpler Prognostic Score (IPS‐3) for advanced Hodgkin lymphoma in the modern era

R. Advani, R. Gascoyne, L. Gordon, 2015, British journal of haematology.

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.

R. Advani, R. Gascoyne, L. Gordon, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B‐cell non‐Hodgkin lymphoma: ECOG3402

R. Advani, R. Gascoyne, S. Horning, 2015, British journal of haematology.

Just enough palliation: radiation dose and outcome in patients with non-small-cell lung cancer.

H. Wagner, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thoracic irradiation for patients with resected non-small cell lung cancer: adjuvant or salvage?

H. Wagner, 2006, Cancer journal.

Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.

H. Wakelee, R. Komaki, R. Marks, 2005, Lung cancer.

Postoperative radiation therapy for patients who have resected non-small cell lung cancer.

H. Wagner, 2005, Hematology/oncology clinics of North America.

Should All Patients With SCLC Receive Prophylactic Cranial Irradiation If They Have Responded to Treatment

B. Slotman, H. Wagner, 2015 .

Image-guided conformal radiation therapy planning and delivery for non-small-cell lung cancer.

H. Wagner, 2003, Cancer control : journal of the Moffitt Cancer Center.

Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer

G. Bepler, C. Stevens, T. Dilling, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combined effect of diethyldithiocarbamate (DDC) and modest hyperthermia on Chinese hamster (V79) cell survival and DNA strand break repair following photon irradiation.

E. Sternick, H. Madoc‐Jones, D. Parkinson, 1984, International journal of radiation oncology, biology, physics.

Efficacy and tolerability of ABVD and Stanford V for elderly advanced-stage Hodgkin lymphoma (HL): Analysis from the phase III randomized U.S. Intergroup Trial E2496.

R. Advani, L. Gordon, J. Connors, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD + Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496

R. Advani, R. Gascoyne, L. Gordon, 2011 .

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group.

S. Adak, D. Johnson, H. Wagner, 2000, The Annals of thoracic surgery.

Assessing patient accrual to cooperative group lung cancer trials: why are rates disappointing?

Charles R. Thomas, C. Langer, B. Lally, 2011, Journal of Thoracic Oncology.

Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.

M. Mehta, D. Scholtens, D. Cella, 2001, International journal of radiation oncology, biology, physics.

A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

J P Pignon, M. Tattersall, R. Souhami, 1992, The New England journal of medicine.

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.

S. Adak, R. Livingston, M. Perry, 2000, The New England journal of medicine.

Small bowel metastasis from lung cancer detected on FDG PET/CT.

H. Wagner, M. Tulchinsky, S. Coquia, 2009, Clinical nuclear medicine.

Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881.

S. Piantadosi, J. Ruckdeschel, H. Wagner, 1994, Chest.

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.

D. Ettinger, A. Turrisi, D. Johnson, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interdigitated therapy of patients with stage IIIA and IIIB Non-Small Cell Lung Cancer with alternating courses of BID Thoracic Irradiation (TI) and Chemotherapy (CT) with Cisplatin-Etoposide - Results of a pilot study

D. Johnson, H. Wagner, A. T. Turrial, 1991 .

R. Livingston, W. Sause, A. Turrisi, 2000, Cancer.

Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.

B. Movsas, H. Wagner, C. Scott, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy followed by standard thoracic radiotherapy vs. hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small cell lung cancer: phase III study of the eastern cooperative oncology group (ECOG 2597)

M. Mehta, J. Schiller, H. Wagner, 2003 .

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

R. Neves, J. Drabick, T. Schell, 2017, Cancer biology & therapy.

Treatment of stage IIIA non-small cell lung cancer.

H. Wagner, J. Ruckdeschel, L. Robinson, 2003, Chest.

Exogenous IL2 partially reverts CML non-reactivity acquired during prophylactic immunosuppression with cyclosporin A of human allograft recipients.

C. Huber, R. Margreiter, H. Wagner, 1986, Immunobiology.